HUMPHREY RACHEL sold PYXS
April 17, 2025 · Form 4 insider transaction
HUMPHREY RACHEL sold 200 shares of Pyxis Oncology, Inc. at $0.97 per share, a transaction worth $194.00. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 342 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$0.97
Total value
$194.00
InsiderHUMPHREY RACHEL
RoleDirector
CompanyPyxis Oncology, Inc. (PYXS)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 17, 2025
Filing dateMarch 25, 2026
Shares owned after95,205
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024.